ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 15 analysts with an average price target of $12.73. This is a potential upside of $10.54 (481.28%) from yesterday's end of day stock price of $2.19.

Allogene Therapeutics's activity chart (see below) currently has 104 price targets and 118 ratings on display. The stock rating distribution of ALLO is 2.27% SELL, 84.09% BUY and 13.64% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.13% with an average time for these price targets to be met of 80.79 days.

Highest price target for ALLO is $14, Lowest price target is $4.6, average price target is $12.73.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 1 are a SELL (2.27%), 37 are a BUY (84.09%), 6 are a HOLD (13.64%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$6.5 (260.00%)

$9

28 days ago
(08-Nov-2024)

0/9 (0%)

$5.89 (189.39%)

Buy

$14

$11.5 (460.00%)

3 months 27 days ago
(09-Aug-2024)

2/10 (20%)

$11.68 (503.45%)

94

Buy

$14

$11.5 (460.00%)

3 months 28 days ago
(08-Aug-2024)

1/3 (33.33%)

$11.64 (493.22%)

192

Buy

$11

$8.5 (340.00%)

$30

6 months 5 days ago
(31-May-2024)

2/7 (28.57%)

$8.5 (340.00%)

3

Buy

$13

$10.5 (420.00%)

$28

6 months 15 days ago
(21-May-2024)

2/9 (22.22%)

$10.31 (383.27%)

195

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 80.79 days on average for the stock forecasts to be realized with a an average price target met ratio 24.13

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 4 price targets and 2 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $29.5

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?